Specific targeting of the EBV lytic phase protein BNLF2a to the transporter associated with antigen processing results in impairment of HLA class I-restricted antigen presentation

Journal of Immunology

Volumn 182, Issue 4, 2009, Pages 2313-2324

  Horst, Daniëlle ^a,d   Van Leeuwen, Daphne ^a   Croft, Nathan P ^b   Garstka, Malgorzata A ^a   Hislop, Andrew D ^b   Kremmer, Elisabeth ^c   Rickinson, Alan B ^b   Wiertz, Emmanuel J H J ^a,d   Ressing, Maaike E ^a,d  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; HLA ANTIGEN CLASS 1; PROTEIN BNLF2A; TAPASIN; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 2; UNCLASSIFIED DRUG; VIRUS PROTEIN; ABC TRANSPORTER; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING (TAP);

ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENDOPLASMIC RETICULUM; EPSTEIN BARR VIRUS; HERPES VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; VIROGENESIS; VIRUS REPLICATION; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSDUCTION; GENETICS; IMMUNOLOGY; IMMUNOPRECIPITATION; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INFECTION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; CELL LINE; EPSTEIN-BARR VIRUS INFECTIONS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HERPESVIRUS 4, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOPRECIPITATION; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSDUCTION, GENETIC; VIRAL PROTEINS;

EID: 61449138716     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803218     Document Type: Article

References (67)

1. Lehner, P. J., M. J. Surman, and P. Cresswell. 1998. Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line .220. Immunity 8: 221-231.
2. Sadasivan, B., P. J. Lehner, B. Ortmann, T. Spies, and P. Cresswell. 1996. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 5: 103-114.
3. Kienast, A., M. Preuss, M. Winkler, and T. P. Dick. 2007. Redox regulation of peptide receptivity of major histocompatibility complex class I molecules by ERp57 and tapasin. Nat. Immunol. 8: 864-872.
4. Wearsch, P. A., and P. Cresswell. 2007. Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer. Nat. Immunol. 8: 873-881.
5. Vossen, M. T., E. M. Westerhout, C. Soderberg-Naucler, and E. J. Wiertz. 2002. Viral immune evasion: a masterpiece of evolution. Immunogenetics 54: 527-542.
6. Wiertz, E. J., S. Mukherjee, and H. L. Ploegh. 1997. Viruses use stealth technology to escape from the host immune system. Mol. Med. Today 3: 116-123.
7. Yewdell, J. W., and A. B. Hill. 2002. Viral interference with antigen presentation. Nat. Immunol. 3: 1019-1025.
8. Lilley, B. N., and H. L. Ploegh. 2005. Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond. Immunol. Rev. 207: 126-144.
9. Gruhler, A., P. A. Peterson, and K. Fruh. 2000. Human cytomegalovirus immediate early glycoprotein US3 retains MHC class I molecules by transient association. Traffic 1: 318-325.
10. Park, B., Y. Kim, J. Shin, S. Lee, K. Cho, K. Fruh, S. Lee, and K. Ahn. 2004. Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. Immunity 20: 71-85.
11. Ziegler, H., R. Thale, P. Lucin, W. Muranyi, T. Flohr, H. Hengel, H. Farrell, W. Rawlinson, and U. H. Koszinowski. 1997. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 6: 57-66.
12. Wiertz, E. J., T. R. Jones, L. Sun, M. Bogyo, H. J. Geuze, and H. L. Ploegh. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84: 769-779.
13. Wiertz, E. J. H. J., D. Tortorella, M. Bogyo, J. Yu, W. Mothes, T. R. Jones, T. A. Rapoport, and H. L. Ploegh. 1996. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384: 432-438.
14. 2-herpesviruses. Proc. Natl. Acad. Sci. USA 97: 8455-8460.
15. Boname, J. M., and P. G. Stevenson. 2001. MHC class I ubiquitination by a viral PHD/LAP finger protein. Immunity 15: 627-636.
16. Boname, J. M., B. D. de Lima, P. J. Lehner, and P. G. Stevenson. 2004. Viral degradation of the MHC class I peptide loading complex. Immunity 20: 305-317.
17. 2-microglobulin assembly. J. Virol. 76: 2796-2803.
18. Lybarger, L., X. Wang, M. R. Harris, H. W. Virgin, and T. H. Hansen. 2003. Virus subversion of the MHC class I peptide-loading complex. Immunity 18: 121-130.
19. Coscoy, L., and D. Ganem. 2000. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc. Natl. Acad. Sci. USA 97: 8051-8056.
20. Ishido, S., C. Wang, B. S. Lee, G. B. Cohen, and J. U. Jung. 2000. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcomaassociated herpesvirus K3 and K5 proteins. J. Virol. 74: 5300-5309.
21. Lehner, P. J., S. Hoer, R. Dodd, and L. M. Duncan. 2005. Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases. Immunol. Rev. 207: 112-125.
22. Hudson, A. W., P. M. Howley, and H. L. Ploegh. 2001. A human herpesvirus 7 glycoprotein, U21, diverts major histocompatibility complex class I molecules to lysosomes. J. Virol. 75: 12347-12358.
23. Hudson, A. W., D. Blom, P. M. Howley, and H. L. Ploegh. 2003. The ERlumenal domain of the HHV-7 immunoevasin U21 directs class I MHC molecules to lysosomes. Traffic 4: 824-837.
24. Reusch, U., W. Muranyi, P. Lucin, H. G. Burgert, H. Hengel, and U. H. Koszinowski. 1999. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J. 18: 1081-1091.
25. Ahn, K., T. H. Meyer, S. Uebel, P. Sempe, H. Djaballah, Y. Yang, P. A. Peterson, K. Fruh, and R. Tampe. 1996. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J. 15: 3247-3255.
26. Fruh, K., K. Ahn, H. Djaballah, P. Sempe, P. M. van Endert, R. Tampe, P. A. Peterson, and Y. Yang. 1995. A viral inhibitor of peptide transporters for antigen presentation. Nature 375: 415-418.
27. Galocha, B., A. Hill, B. C. Barnett, A. Dolan, A. Raimondi, R. F. Cook, J. Brunner, D. J. McGeoch, and H. L. Ploegh. 1997. The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues. J. Exp. Med. 185: 1565-1572.
28. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375: 411-415.
29. Neumann, L., W. Kraas, S. Uebel, G. Jung, and R. Tampe. 1997. The active domain of the herpes simplex virus protein ICP47: a potent inhibitor of the transporter associated with antigen processing. J. Mol. Biol. 272: 484-492.
30. Tomazin, R., A. B. Hill, P. Jugovic, I. York, P. van Endert, H. L. Ploegh, D. W. Andrews, and D. C. Johnson. 1996. Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J. 15: 3256-3266.
31. + T lymphocytes. Cell 77: 525-535.
32. Lacaille, V. G., and M. J. Androlewicz. 1998. Herpes simplex virus inhibitor ICP47 destabilizes the transporter associated with antigen processing (TAP) heterodimer. J. Biol. Chem. 273: 17386-17390.
33. Koppers-Lalic, D., E. A. Reits, M. E. Ressing, A. D. Lipinska, R. Abele, J. Koch, R. M. Marcondes, P. Admiraal, D. van Leeuwen, K. Bienkowska-Szewczyk, et al. 2005. Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. Proc. Natl. Acad. Sci. USA 102: 5144-5149.
34. Koppers-Lalic, D., M. C. Verweij, A. D. Lipinska, Y. Wang, E. Quinten, E. A. Reits, J. Koch, S. Loch, M. M. Rezende, F. Daus, et al. 2008. Varicellovirus UL 49.5 proteins differentially affect the function of the transporter associated with antigen processing, TAP. PLoS Pathog. 4: e1000080.
35. Ahn, K., A. Gruhler, B. Galocha, T. R. Jones, E. J. Wiertz, H. L. Ploegh, P. A. Peterson, Y. Yang, and K. Fruh. 1997. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6: 613-621.
36. Hengel, H., J. O. Koopmann, T. Flohr, W. Muranyi, E. Goulmy, G. J. Hammerling, U. H. Koszinowski, and F. Momburg. 1997. A viral ERresident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6: 623-632.
37. Hewitt, E. W., S. S. Gupta, and P. J. Lehner. 2001. The human cytomegalovirus gene product US6 inhibits ATP binding by TAP. EMBO J. 20: 387-396.
38. Kyritsis, C., S. Gorbulev, S. Hutschenreiter, K. Pawlitschko, R. Abele, and R. Tampe. 2001. Molecular mechanism and structural aspects of transporter associated with antigen processing inhibition by the cytomegalovirus protein US6. J. Biol. Chem. 276: 48031-48039.
39. Lehner, P. J., J. T. Karttunen, G. W. Wilkinson, and P. Cresswell. 1997. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc. Natl. Acad. Sci. USA 94: 6904-6909.
40. Gottschalk, S., H. E. Heslop, and C. M. Roon. 2002. Treatment of Epstein-Barr virus-associated malignancies with specific T cells. Adv. Cancer Res. 84: 175-201.
41. Ressing, M. E., S. E. Keating, D. van Leeuwen, D. Koppers-Lalic, I. Y. Pappworth, E. J. Wiertz, and M. Rowe. 2005. Impaired transporter associated with antigen processing-dependent peptide transport during productive EBV infection. J. Immunol. 174: 6829-6838.
42. + T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates. J. Exp. Med. 204: 1863-1873.
43. Barnstable, C. J., W. F. Bodmer, G. Brown, G. Galfre, C. Milstein, A. F. Williams, and A. Ziegler. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell 14: 9-20.
44. Hochstenbach, F., V. David, S. Watkins, and M. B. Brenner. 1992. Endoplasmic reticulum resident protein of 90 kilodaltons associates with the T- and B-cell antigen receptors and major histocompatibility complex antigens during their assembly. Proc. Natl. Acad. Sci. USA 89: 4734-4738.
45. van den Born, E., C. C. Posthuma, K. Knoops, and E. J. Snijder. 2007. An infectious recombinant equine arteritis virus expressing green fluorescent protein from its replicase gene. J. Gen. Virol. 88: 1196-1205.
46. van Ham, S. M., E. P. Tjin, B. F. Lillemeier, U. Gruneberg, K. E. van Meijgaarden, L. Pastoors, D. Verwoerd, A. Tulp, B. Canas, D. Rahman, et al. 1997. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading. Curr. Biol. 7: 950-957.
47. Reits, E. A., J. C. Vos, M. Gromme, and J. Neefjes. 2000. The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature 404: 774-778.
48. Oosten, L. E., D. Koppers-Lalic, E. Blokland, A. Mulder, M. E. Ressing, T. Mutis, A. G. van Halteren, E. J. Wiertz, and E. Goulmy. 2007. TAP-inhibiting proteins US6, ICP47 and UL49.5 differentially affect minor and major histocompatibility antigen-specific recognition by cytotoxic T lymphocytes. Int. Immunol. 19: 1115-1122.
49. Salter, R. D., D. N. Howell, and P. Cresswell. 1985. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 21: 235-246.
50. Shimizu, Y., and R. DeMars. 1989. Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. J. Immunol. 142: 3320-3328.
51. Karttunen, J. T., P. J. Lehner, S. S. Gupta, E. W. Hewitt, and P. Cresswell. 2001. Distinct functions and cooperative interaction of the subunits of the transporter associated with antigen processing (TAP). Proc. Natl. Acad. Sci. USA 98: 7431-7436.
52. de la Salle, H., D. Hanau, D. Fricker, A. Urlacher, A. Kelly, J. Salamero, S. H. Powis, L. Donato, H. Bausinger, M. Laforet, et al. 1994. Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science 265: 237-241.
53. de la Salle, H., J. Zimmer, D. Fricker, C. Angenieux, J. P. Cazenave, M. Okubo, H. Maeda, A. Plebani, M. M. Tongio, A. Dormoy, and D. Hanau. 1999. HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1. J. Clin. Invest 103: R9-R13.
54. Verweij, M. C., D. Koppers-Lalic, S. Loch, F. Klauschies, H. de la Salle, E. Quinten, P. J. Lehner, A. Mulder, M. R. Knittler, R. Tampe, et al. 2008. The varicellovirus UL49.5 protein blocks the transporter associated with antigen processing (TAP) by inhibiting essential conformational transitions in the 6+6 transmembrane TAP core complex. J. Immunol. 181: 4894-4907.
55. Feederle, R., M. Kost, M. Baumann, A. Janz, E. Drouet, W. Hammerschmidt, and H. J. Delecluse. 2000. The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J. 19: 3080-3089.
56. Ovstebo, R., K. B. Haug, K. Lande, and P. Kierulf. 2003. PCR-based calibration curves for studies of quantitative gene expression in human monocytes: development and evaluation. Clin. Chem. 49: 425-432.
57. Kleijmeer, M. J., A. Kelly, H. J. Geuze, J. W. Slot, A. Townsend, and J. Trowsdale. 1992. Location of MHC-encoded transporters in the endoplasmic reticulum and cis-Golgi. Nature 357: 342-344.
58. Russ, G., F. Esquivel, J. W. Yewdell, P. Cresswell, T. Spies, and J. R. Bennink. 1995. Assembly, intracellular localization, and nucleotide binding properties of the human peptide transporters TAP1 and TAP2 expressed by recombinant vaccinia viruses. J. Biol. Chem. 270: 21312-21318.
59. Stam, N. J., H. Spits, and H. L. Ploegh. 1986. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J. Immunol. 137: 2299-2306.
60. Seliger, B., U. Ritz, R. Abele, M. Bock, R. Tampe, G. Sutter, I. Drexler, C. Huber, and S. Ferrone. 2001. Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway. Cancer Res. 61: 8647-8650.
61. Copeman, J., N. Bangia, J. C. Cross, and P. Cresswell. 1998. Elucidation of the genetic basis of the antigen presentation defects in the mutant cell line .220 reveals polymorphism and alternative splicing of the tapasin gene. Eur. J. Immunol. 28: 3783-3791.
62. Beinert, D., L. Neumann, S. Uebel, and R. Tampe. 1997. Structure of the viral TAP-inhibitor ICP47 induced by membrane association. Biochemistry 36: 4694-4700.
63. Pfander, R., L. Neumann, M. Zweckstetter, C. Seger, T. A. Holak, and R. Tampe. 1999. Structure of the active domain of the herpes simplex virus protein ICP47 in water/sodium dodecyl sulfate solution determined by nuclear magnetic resonance spectroscopy. Biochemistry 38: 13692-13698.
64. Halenius, A., F. Momburg, H. Reinhard, D. Bauer, M. Lobigs, and H. Hengel. 2006. Physical and functional interactions of the cytomegalovirus US6 glycoprotein with the transporter associated with antigen processing. J. Biol. Chem. 281: 5383-5390.
65. Loch, S., F. Klauschies, C. Scholz, M. C. Verweij, E. J. Wiertz, J. Koch, and R. Tampe. 2008. Signaling of a varicelloviral factor across the endoplasmic reticulum membrane induces destruction of the peptide-loading complex and immune evasion. J. Biol. Chem. 283: 13428-13436.
66. Yuan, J., E. Cahir-McFarland, B. Zhao, and E. Kieff. 2006. Virus and cell RNAs expressed during Epstein-Barr virus replication. J. Virol. 80: 2548-2565.
67. Lipinska, A. D., D. Koppers-Lalic, M. Rychlowski, P. Admiraal, F. A. Rijsewijk, K. Bienkowska-Szewczyk, and E. J. Wiertz. 2006. Bovine herpesvirus 1 UL49.5 protein inhibits the transporter associated with antigen processing despite complex formation with glycoprotein M. J. Virol. 80: 5822-5832.